Capsaicin treatment of idiopathic rhinitis: The new panacea?

Current Allergy and Asthma Reports

Volumn 6, Issue 2, 2006, Pages 132-137

  Van Rijswijk, Jeroen B ^b   Van Wijk, Roy Gerth ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CAPSAICIN; CORTICOSTEROID; IPRATROPIUM BROMIDE; LIGAND; RESINIFERATOXIN; VANILLOID RECEPTOR 1;

ALLERGIC RHINITIS; ASTHMA; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG FATALITY; DRUG MECHANISM; HUMAN; INFLAMMATION; NEUROPATHY; NONHUMAN; NOSE DISEASE; NOSE MUCOSA; PATHOPHYSIOLOGY; PATIENT CARE; PERENNIAL RHINITIS; PHENOTYPE; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; TREATMENT RESPONSE;

ANIMALS; CAPSAICIN; HUMANS; RHINITIS;

EID: 33645755443     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-006-0051-2     Document Type: Review

References (49)

1. Bousquet J, Van Cauwenberge P, Khaltaev N: Allergic rhinitis and its impact on asthma (ARIA). J Allergy Clin Immunol 2001, 108:S147-S334.
2. Philip G, Togias AG: Nonallergic rhinitis: pathophysiology and models for study. Eur Arch Otorhinolaryngol Suppl 1995, 1:S27-S32.
3. Mikaelian AJ: Vasomotor rhinitis (review). Ear Nose Throat J 1989, 68:207-210.
4. Small P, Black M, Frenkiel S: Effects of treatment with beclomethasone dipropionate in subpopulations of perennial rhinitis patients. J Allergy Clin Immunol 1982, 70:178-182.
5. Braunstahl GJ, Overbeek SE, Fokkens WJ, et al.: Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Grit Care Med 2001, 164:858-865.
6. Fokkens WJ, Holm AU, Rijntjes E, et al.: Characterization and quantification of cellular infiltrates in nasal mucosa of patients with grass pollen allergy, non-allergic patients with nasal polyps and controls. Int Arch Allergy Appl Immunol 1990, 93:66-72.
7. Blom HM, Godthelp T, Fokkens WJ, et al.: Mast cells, eosinophils and IgE-positive cells in the nasal mucosa of patients with vasomotor rhinitis: an immunohistochemical study. Eur Arch Otorhinolaryngol Suppl 1995, 1:S33-S39.
8. Blom HM, Severijnen LA, Van Rijswijk JB, et al.: The long-term effects of capsakin aqueous spray on the nasal mucosa. Clin Exp Allergy 1998, 28:1351-1358.
9. Powe DG, Huskisson RS, Carney AS, et al.: Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy 2001, 31:864-872.
10. Blom HM, Godthelp T, Fokkens WF, et al.: The effect of nasal steroid aqueous spray on nasal complaint scores and cellular infiltrates in the nasal mucosa of patients with a non-allergic non-infectious perennial rhinitis. J Allergy Clin Immunol 1997, 100:739-747.
11. Blom HM, Van Rijswijk JB, Garrelds IM, et al.: Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis: a placebo-controlled study. Clin Exp Allergy 1997, 27:796-801.
12. Gerth Van Wijk R, Terreehorst IT, Mulder PC, et al.: Intranasal capsaicin is lacking therapeutic effect in perennial allergic rhinitis to house dust mite: a placebo-controlled study. Clin Exp Allergy 2000, 30:1792-1798.
13. Baraniuk JN: Sensory, parasympathetic, and sympathetic neural influences in the nasal mucosa. J Allergy Clin Immunol 1992, 90:1045-1050.
14. Sanico A, Togias A: Noninfectious, nonallergic rhinitis (NINAR): considerations on possible mechanisms. Am J Rhinol 1998, 12:65-72.
15. Malcomson KG: The vasomotor activities of the nasal mucous membrane. J Laryngol 1959, 73:73-75.
16. Lung MA: The role of the autonomic nerves in the control of nasal circulation. Biol Signals 1995, 4:179-185.
17. Kimmelman CP, Ali GH: Vasomotor rhinitis. Otolaryngol Clin North Am 1986, 19:65-71.
18. Jones AS, Lancer JM: Vasomotor rhinitis (editorial). Br Med J 1987, 294:1505-1506.
19. Wilde AD, Cook JA, Jones AS: The nasal response to isometric exercise in non-eosinopbilic intrinsic rhinitis. Clin Otolaryngol 1996, 21:84-86.
20. Wilde AD, Jones AS: The nasal response to axillary pressure. Clin Otolaryngol 1996, 21:442-444.
21. Lundblad L, Lundberg JM, Brodin E, Anggard A: Origin and distribution of capsaicin-sensitive substance-P-immunoreactive nerves in the nasal mucosa. Acta Otolaryngol 1983, 96:485-493.
22. Uddman R, Alumets J, Densert O, et al.: Occurence and distribution of VIP nerves in the nasal mucosa and the tracheobronchial wall. Acta Otolaryngol 1978, 85:443-448.
23. Baraniuk JN: Neuropeptides. Am J Rhinol 1998, 12:9-16.
24. Baraniuk JN, Kaliner MA: Neuropeptides and nasal secretion. J Allergy Clin Immunol 1990, 86:620-627.
25. Fang SY, Shen CL: Neuropeptide innervation and neuroendocrine cells in allergic rhinitis and chronic hypertrophic rhinitis. Clin Exp Allergy 1998, 28:228-232.
26. Lacroix JS, Kurt AM, Pochon N, et al.: Neutral endopeptidase activity and concentration of sensory neuropeptide in the human nasal mucosa. Eur Arch Otorhinolaryngol 1995, 252:465-468.
27. Anggard A: Basic mechanisms in autonomic nervous responses in specific and nonspecific nasal hyperreactivity. Acta Otolaryngol 1993, 113:394-396.
28. Sanico AM, Atsuta S, Proud D, Togias A: Dose-dependent effects of capsaicin nasal challenge: in vivo evidence of human airway neurogenic inflammation. J Allergy Clin Immunol 1997, 100:632-641.
29. Holzer P: Local effector functions of capsaicin sensitive nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988, 24:739-768.
30. Jancso N, Jancso-Gabor A, Szolcsanyi J: Direct evidence of neurogenic inflammation and its prevention by denervation and pretreatment with capsaicin. Br J Pharmacol Chemother 1967:138-151.
31. Wolf C: [New aspects in the pathogenesis and therapy of hyperreflexive rhinopathy]. Laryngol Rhinol Otol (Stuttg) 1988, 67:438-445.
32. Ruffoli R, Fattori B, Giambelluca MA, et al.: Ultracytochemical localization of the NADPH-d activity in the human nasal respiratory mucosa in vasomotor rhinitis. Laryngoscope 2000, 110:1361-1365.
33. Giannessi F, Fattori B, Ursino F, et al.: Ultrastructural and ultracytochemical study of the human nasal respiratory epithelium in vasomotor rhinitis. Acta Otolaryngol 2003, 123:943-949.
34. Anand P: Capsaicin and menthol in the treatment of itch and pain: recently cloned receptors provide the key. Gut 2003, 52:1233-1235.
35. Cruz F: Desensitization of bladder sensory fibers by intravesical capsaicin or capsaicin analogs: a new strategy for treatment of urge incontinence in patients with spinal detrusor hyperreflexia or bladder hypersensitivity disorders. Int Urogynecol J Pelvic Floor Dysfunct 1998, 9:214-220.
36. Fowler CJ, Jewkes D, McDonald WI, et al.: Intravesical capsaicin for neurogenic bladder dysfunction. Lancet 1992, 339:1239.
37. Greaves MW, Wall PD: Pathophysiology of itching. Lancet 1996, 348:938-940.
38. Winter J, Bevan S, Campbell EA: Capsaicin and pain mechanisms. Br J Anaesth 1995, 75:157-168.
39. Caterina MJ, Schumacher MA, Tominaga M, et al.: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389:816-824.
40. Avelino A, Cruz C, Nagy I, Cruz F: Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience 2002, 109:787-798.
41. Avelino A, Cruz F: Peptide immunoreactivity and ultrastructure of rat urinary bladder nerve fibers after topical desensitization by capsaicin or resiniferatoxin. Auton Neurosci 2000, 86:37-46.
42. Lacroix JS, Buvelot JM, Polla BS, Lundberg JM: Improvement of symptoms of non-allergic chronic rhinitis by local treatment with capsaicin. Clin Exp Allergy 1991, 21:595-600.
43. Lacroix JS, Pochon N, Lundberg JM: Increased concentration of sensory neuropeptide in the nasal mucosa from patients with non-allergic chronic rhinitis. In The New Frontiers of Otorhinolaryngology in Europe. Edited by Motto G. Sorrento, Italy: Monduzzi Editore S.p.A.; 1992:59-63.
44. Marabini S, Ciabatti PG, Polli G, et al.: Beneficial effects of intranasal applications of capsaicin in patients with vasomotor rhinitis. Eur Arch Otorhinolaryngol 1991, 248:191-194.
45. Riechelmann H, Davris S, Bader D: [Treatment of perennial non-allergic rhinopathy with capsakin] (German). HNO 1993, 41:475-479.
46. Wolf G, Anderhuber W, Hauser-Kronberger C, Saria A: [Treatment of nonspecific hyper-reflectory rhinopathy (vasomotor rhinitis) with capsaicin]. Laryngorhinootologie 1995, 74:289-293.
47. van Rijswijk JB, Boeke EL, Keizer JM, et al.: Intranasal capsaicin reduces nasal hyperreactivity in idiopathic rhinitis: a double-blind randomised application regimen study. Allergy 2003, 58:754-761.
48. Marciniak BH, Brown B, Peterson B, et al.: Adverse consequences of capsaicin exposure in health care workers. J Am Geriatr Soc 1995, 43:1181-1182.
49. Appendino C, Szallasi A: Eupborbium: modern research on its active principle, resiniferatoxin, revives an ancient medicine. Life Sci 1997, 60:681-696.